Receptor-interacting protein 2 is a marker for resolution of peritoneal dialysis-associated peritonitis
Michelle L. McCully(Robarts Clinical Trials), Joaquı́n Madrenas(Western University), Miren L. Baroja(Robarts Clinical Trials), Lillian Barra(Western University), Aakanksha Jain(Boston Children's Hospital), Ana Salgado(University of Lisbon), Peter G. Blake(Western University), Thu Chau(Robarts Clinical Trials)
Cited by 11
Related Papers
Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV Activity
|Clinical Pharmacology & Therapeutics|2009|208
Harmonized cross-species cell atlases of trigeminal and dorsal root ganglia
|Science Advances|2024|194
Innate Control of Adaptive Immunity: Beyond the Three-Signal Paradigm
|The Journal of Immunology|2017|171
In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model
|Journal of Controlled Release|2014|140
T cell-intrinsic IL-1R signaling licenses effector cytokine production by memory CD4 T cells
|Nature Communications|2018|139